Symphony Health to provide free access to new MetysTM COVID-19 Module for U.S. based life sciences industry during pandemic

RALEIGH, N.C., April 9 (Bernama-GLOBE NEWSWIRE) — PRA Health Sciences (NASDAQ: PRAH) announced today that Symphony Health, a PRA Health Sciences company, will make a 30-day license of its newly released MetysTM COVID-19 Module available to the U.S. life science industry at no charge.

The COVID-19 Module within the Metys platform will provide up to three users per company with access to all drugs and markets within any U.S. geographic region down to CBSA (core-based statistical area). The module will include history back to October 2018 to ensure access to comparative flu season trends in prior years, with March 2020 data becoming available on April 10. Companies may publish or report insights or findings from the data with prior permission from Symphony.

http://mrem.bernama.com/viewsm.php?idm=37126

administrator

Related Articles